TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 10385853

Group type: EXPERIMENTAL
Intervention: Train-of-four (TOF; 4 stimuli at 2 Hz, repeated every 12 s)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Single twitch (ST; 0.1 Hz)
Number of subjects: 20
Study: 7936250

Group type: EXPERIMENTAL
Intervention: 1H‐MRSI in ALS patients
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 1H‐MRSI in ALS-PUMNS patients
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 1H‐MRSI in PSMA patients
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 1H‐MRSI in sequential studies
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 1H‐MRSI
Number of subjects: 12
Study: 3124453

Group type: EXPERIMENTAL
Intervention: Thymopentin treatment (50 mg s.c. 3 times/week for 3 weeks and repeated after 3 months at 50 mg s.c. once a week for 3 months)
Number of subjects: 0
Study: 28554739

Group type: EXPERIMENTAL
Intervention: Descriptive norms questions (e.g., 'What do you do with bikes?')
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Preference questions (e.g., 'What do you like to do with bikes?')
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Prescriptive norms questions (e.g., 'What should you do with books?')
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Preference questions (e.g., 'What do you like about books?')
Number of subjects: 160
Study: 27889725

Group type: EXPERIMENTAL
Intervention: 25 mL/kg IV normal saline over 6-8 hours
Number of subjects: 55

Group type: COMPARATOR
Intervention: Routine fluids
Number of subjects: 55
Study: 25329799

Group type: EXPERIMENTAL
Intervention: Left temporo-parietal junction area stimulation
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Bilateral temporo-parietal junction area stimulation
Number of subjects: 51

Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 51
Study: 23510951

Group type: EXPERIMENTAL
Intervention: Ginger (1g capsules, two doses: one before induction and one 2h after surgery)
Number of subjects: 239

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 239
Study: 20701216

Group type: EXPERIMENTAL
Intervention: VivaSens
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Seal&Protect
Number of subjects: 30
Study: 17070090

Group type: EXPERIMENTAL
Intervention: Mulligan's mobilization with movement (MWM) technique
Number of subjects: 24

Group type: COMPARATOR
Intervention: Sham condition
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 24
Study: 16881064

Group type: EXPERIMENTAL
Intervention: Creatine supplementation
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study: 12365892

Group type: COMPARATOR
Intervention: Classic parotidectomy with sacrifice of the great auricular nerve (Group A)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Great auricular nerve preservation during parotidectomy (Group B)
Number of subjects: 30
Study: 10200837

Group type: EXPERIMENTAL
Intervention: Deep pressure using Grandin's Hug Machine
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo (disengaged Hug Machine)
Number of subjects: 12
Study: 7767852

Group type: EXPERIMENTAL
Intervention: Ceftriaxone 1.5g once daily
Number of subjects: 31

Group type: COMPARATOR
Intervention: Cefotaxime 6g divided into four daily doses
Number of subjects: 31
Study: 2150591

Group type: EXPERIMENTAL
Intervention: CGS 16949A 0.9 mg
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: CGS 16949A 0.6 mg
Number of subjects: 46
Study: 314759

Group type: EXPERIMENTAL
Intervention: Dobutamine 2.5 microgram/kg . min
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Dobutamine 5 microgram/kg . min
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Dobutamine 10 microgram/kg . min during cardiopulmonary bypass
Number of subjects: 23
Study: 31653219

Group type: EXPERIMENTAL
Intervention: Single follow-up home visit intervention group
Number of subjects: 544

Group type: COMPARATOR
Intervention: Usual care control group
Number of subjects: 544
Study: 28255987

Group type: EXPERIMENTAL
Intervention: Phenylephrine
Number of subjects: 185

Group type: EXPERIMENTAL
Intervention: Metaraminol
Number of subjects: 185

Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 185
Study: 25574686

Group type: EXPERIMENTAL
Intervention: GS-5806 (oral RSV fusion inhibitor)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 24066179

Group type: EXPERIMENTAL
Intervention: Timbre manipulation (sinusoidal, flute, piano, synthetic voice tone)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Pure-tone intervals
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Piano tone intervals
Number of subjects: 0
Study: 21839564

Group type: EXPERIMENTAL
Intervention: Health-social transitional care management program (HSTCMP)
Number of subjects: 1700

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 1700
Study: 20006808

Group type: EXPERIMENTAL
Intervention: Bypass surgery (BSX)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Balloon angioplasty (BAP)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Vein BSX
Number of subjects: 0

Group type: COMPARATOR
Intervention: Prosthetic BSX
Number of subjects: 0

Group type: COMPARATOR
Intervention: BAP followed by BSX
Number of subjects: 0
Study: 17156968

Group type: EXPERIMENTAL
Intervention: Personally tailored interactive multimedia computer program (IMCP)
Number of subjects: 49

Group type: COMPARATOR
Intervention: Control group (non-tailored IMCP 'electronic leaflet')
Number of subjects: 49
Study: 15472665

Group type: EXPERIMENTAL
Intervention: 1-visit root canal treatment using AH 26 sealer and laterally compacted gutta-percha
Number of subjects: 218

Group type: COMPARATOR
Intervention: 2-visit root canal treatment with calcium hydroxide-chlorhexidine medication and temporary filling
Number of subjects: 218
Study: 11340880

Group type: EXPERIMENTAL
Intervention: Noninvasive method with sensor fixed to acromion
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Noninvasive method with sensor mounted on adjustable jig
Number of subjects: 0

Group type: COMPARATOR
Intervention: Invasive approach with pins drilled into scapula
Number of subjects: 0
Study: 8980871

Group type: EXPERIMENTAL
Intervention: light or medication
Number of subjects: 45
Study: 8435923

Group type: EXPERIMENTAL
Intervention: Verapamil
Number of subjects: 125

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 125

Group type: EXPERIMENTAL
Intervention: Verapamil (in patients with ST-segment depression)
Number of subjects: 125

Group type: COMPARATOR
Intervention: Placebo (in patients with ST-segment depression)
Number of subjects: 125
Study: 3092658

Group type: EXPERIMENTAL
Intervention: Enprostil (35 micrograms twice daily)
Number of subjects: 87

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 87
Study: 31570085

Group type: EXPERIMENTAL
Intervention: Thrombectomy with the Trevo device
Number of subjects: 206

Group type: COMPARATOR
Intervention: Best medical therapy
Number of subjects: 206
Study: 29101314

Group type: EXPERIMENTAL
Intervention: Bryan cervical artificial disc replacement (ADR)
Number of subjects: 49

Group type: COMPARATOR
Intervention: ACDF (anterior cervical discectomy and fusion)
Number of subjects: 49
Study: 25976743

Group type: EXPERIMENTAL
Intervention: Denosumab
Number of subjects: 84

Group type: COMPARATOR
Intervention: Zoledronic acid
Number of subjects: 84
Study: 23902798

Group type: EXPERIMENTAL
Intervention: Technology-enhanced group tele-consultation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Standard group tele-consultation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Fidelity assessment with no consultation
Number of subjects: 0
Study: 21980775

Group type: EXPERIMENTAL
Intervention: LMA Supreme
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: i-gel
Number of subjects: 60
Study: 19291121

Group type: EXPERIMENTAL
Intervention: Solvent-free (SF) formulation
Number of subjects: 12

Group type: COMPARATOR
Intervention: Solvent-containing (SC) formulation
Number of subjects: 12
Study: 16790651

Group type: EXPERIMENTAL
Intervention: HIGH-group: 9.5 mg hyperbaric bupivacaine + 2.5 microg sufentanil
Number of subjects: 50

Group type: COMPARATOR
Intervention: LOW-group: 6.5 mg hyperbaric bupivacaine + 2.5 microg sufentanil
Number of subjects: 50
Study: 15055096

Group type: EXPERIMENTAL
Intervention: Iyengar yoga course (2 classes per week for 5 weeks)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Wait-list control group
Number of subjects: 28
Study: 11105535

Group type: COMPARATOR
Intervention: Conventional amphotericin B 1 mg kg‐1 per day
Number of subjects: 193

Group type: EXPERIMENTAL
Intervention: Liposomal amphotericin B 1 mg kg‐1 per day
Number of subjects: 193

Group type: EXPERIMENTAL
Intervention: Liposomal amphotericin B 3 mg kg‐1 per day
Number of subjects: 193

Group type: COMPARATOR
Intervention: Conventional amphotericin B
Number of subjects: 193

Group type: EXPERIMENTAL
Intervention: Liposomal amphotericin B 1 mg kg‐1
Number of subjects: 193

Group type: EXPERIMENTAL
Intervention: Liposomal amphotericin B 3 mg kg‐1
Number of subjects: 193
Study: 19361151

Group type: EXPERIMENTAL
Intervention: Oral contraceptives (OCs)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Control (off OCs)
Number of subjects: 10
Study: 1376826

Group type: EXPERIMENTAL
Intervention: Antihypertensive therapy
Number of subjects: 0
Study: 3885425

Group type: EXPERIMENTAL
Intervention: Metronidazole tablets (2 g single dose)
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Benzoyl metronidazole suspension (2 g single dose)
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Tinidazole tablets (2 g single dose)
Number of subjects: 3
Study: 3611299

Group type: COMPARATOR
Intervention: Oral influenza immunization in elderly volunteers
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Oral influenza immunization in young mice
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Oral influenza immunization in older mice
Number of subjects: 0

Group type: COMPARATOR
Intervention: Oral influenza immunization
Number of subjects: 0

Group type: COMPARATOR
Intervention: Parenteral influenza immunization
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Secretory IgA (SIgA) antibody response
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Salivary antibody response in elderly
Number of subjects: 0
Study: 31888725

Group type: EXPERIMENTAL
Intervention: RCTs with poor recruitment
Number of subjects: 77

Group type: COMPARATOR
Intervention: Completed RCTs
Number of subjects: 77
Study: 28876220

Group type: EXPERIMENTAL
Intervention: Surgical wound dressing group
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Modified surgical wound dressing group
Number of subjects: 84

Group type: COMPARATOR
Intervention: Traditional care group
Number of subjects: 84
Study: 26383578

Group type: EXPERIMENTAL
Intervention: Ultrasonic knife
Number of subjects: 40

Group type: COMPARATOR
Intervention: Electric knife
Number of subjects: 40
Study: 22799766

Group type: EXPERIMENTAL
Intervention: Dietary educational program focusing on decreasing sodium and increasing potassium through cooking instructions and self-monitoring of the diet.
Number of subjects: 71

Group type: COMPARATOR
Intervention: Control group (no intervention).
Number of subjects: 71
Study: 21701062

Group type: EXPERIMENTAL
Intervention: real repetitive transcranial magnetic stimulation (rTMS)
Number of subjects: 32

Group type: COMPARATOR
Intervention: sham rTMS
Number of subjects: 32
Study: 18444059

Group type: EXPERIMENTAL
Intervention: Evidence-based psychosocial treatments (EBTs)
Number of subjects: 0
Study: 16434737

Group type: EXPERIMENTAL
Intervention: Fluoride varnish once/year
Number of subjects: 376

Group type: EXPERIMENTAL
Intervention: Fluoride varnish twice/year
Number of subjects: 376

Group type: COMPARATOR
Intervention: Counseling only
Number of subjects: 376
Study: 12898088

Group type: COMPARATOR
Intervention: Full-vision trials (VC5)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Blocked vision trials (various latencies)
Number of subjects: 0
Study: 10882226

Group type: EXPERIMENTAL
Intervention: Inhaled corticosteroid (fluticasone propionate, FP, 250 microg twice daily)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Short-acting beta-agonist (salbutamol, Sb, 400 microg twice daily)
Number of subjects: 30
Study: 9085466

Group type: EXPERIMENTAL
Intervention: Hydrolyzed casein-based formula
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Soy-protein based formula
Number of subjects: 26

Group type: COMPARATOR
Intervention: Age-matched controls on a free diet
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Both CMPA groups
Number of subjects: 26
Study: 8267238

Group type: EXPERIMENTAL
Intervention: Needleless system
Number of subjects: 97

Group type: COMPARATOR
Intervention: Conventional heparin lock
Number of subjects: 97
Study: 3884131

Group type: EXPERIMENTAL
Intervention: 5-fluorouracil (5-FU) + semustine (MeCCNU) chemotherapy
Number of subjects: 180

Group type: COMPARATOR
Intervention: Observation only (Control)
Number of subjects: 180
Study: 31260569

Group type: EXPERIMENTAL
Intervention: Bifrontal ECT
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Right unilateral ECT
Number of subjects: 120

Group type: COMPARATOR
Intervention: Bitemporal ECT
Number of subjects: 120
Study: 28759735

Group type: EXPERIMENTAL
Intervention: 250 mL of 2% fat milk
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: 250 mL of soy beverage
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: 175 g of 2% Greek yogurt
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: 30 g of Cheddar cheese
Number of subjects: 30

Group type: COMPARATOR
Intervention: Water (energy-free control)
Number of subjects: 30
Study: 26308174

Group type: EXPERIMENTAL
Intervention: Propranolol at siponimod steady state (group A)
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: Siponimod at propranolol steady state (group B)
Number of subjects: 76

Group type: COMPARATOR
Intervention: Propranolol alone (group D)
Number of subjects: 76

Group type: COMPARATOR
Intervention: Placebo (group C)
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: Coadministration of siponimod and propranolol
Number of subjects: 76
Study: 24050855

Group type: EXPERIMENTAL
Intervention: Epsilon aminocaproic acid (EACA)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Tranexamic acid (TXA)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Both EACA and TXA
Number of subjects: 64
Study: 22068581

Group type: EXPERIMENTAL
Intervention: Enhanced website (intervention)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Basic text-based website (comparison)
Number of subjects: 24
Study: 19142758

Group type: EXPERIMENTAL
Intervention: Olmesartan (20 mg/day) administered at bedtime
Number of subjects: 123

Group type: COMPARATOR
Intervention: Olmesartan (20 mg/day) administered upon awakening
Number of subjects: 123
Study: 17209146

Group type: EXPERIMENTAL
Intervention: Antidepressant treatment in MDD-HF subjects
Number of subjects: 61

Group type: COMPARATOR
Intervention: Nondepressed HF subjects
Number of subjects: 61

Group type: COMPARATOR
Intervention: Healthy control subjects
Number of subjects: 61
Study: 15025735

Group type: EXPERIMENTAL
Intervention: Fluticasone proprionate (FP) 2000 micro g daily for 2 weeks
Number of subjects: 20
Study: 11862344

Group type: EXPERIMENTAL
Intervention: buprenorphine/naloxone (4/1, 8/2, 16/4, 32/8 mg)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: buprenorphine (32 mg)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: buprenorphine/naloxone
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: buprenorphine/naloxone and buprenorphine
Number of subjects: 6
Study: 9814400

Group type: COMPARATOR
Intervention: Oral amoxicillin (50 mg/kg/day divided tid)
Number of subjects: 170

Group type: EXPERIMENTAL
Intervention: Intramuscular penicillin (50,000 units/kg)
Number of subjects: 170

Group type: EXPERIMENTAL
Intervention: General appearance in children less than two years of age
Number of subjects: 170

Group type: COMPARATOR
Intervention: Failure by all three main outcome measures
Number of subjects: 170

Group type: COMPARATOR
Intervention: Hospitalization at follow-up visit
Number of subjects: 170
Study: 7616304

Group type: EXPERIMENTAL
Intervention: albendazole
Number of subjects: 407

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 407
Study: 2796618

Group type: EXPERIMENTAL
Intervention: 3 mL of 0.5% Bupivacaine
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: 3 mL of 0.5% Bupivacaine with 1 mL 10% G/W
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: 2 mL of 0.5% Bupivacaine with 1 mL 10% G/W
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: 3 mL of 0.5% Bupivacaine in 8% glucose
Number of subjects: 80

Group type: COMPARATOR
Intervention: Plain Bupivacaine
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Hyperbaric Bupivacaine
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: 4 mL of hyperbaric Bupivacaine
Number of subjects: 80
Study: 648737

Group type: EXPERIMENTAL
Intervention: Potassium chloride (Slow‐K 600 mg three times daily)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Spironolactone (Aldactone A 25 mg four times daily)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Frusemide alone
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Frusemide plus Aldactone-A
Number of subjects: 0

Group type: COMPARATOR
Intervention: Frusemide plus Slow-K
Number of subjects: 0
Study: 31293259

Group type: EXPERIMENTAL
Intervention: Early oral feeding (initiated at 8 hours post-operation)
Number of subjects: 282

Group type: COMPARATOR
Intervention: Delayed oral feeding (initiated at 48 hours post-operation)
Number of subjects: 282

Group type: EXPERIMENTAL
Intervention: Early oral feeding
Number of subjects: 282

Group type: COMPARATOR
Intervention: Delayed oral feeding
Number of subjects: 282
Study: 28692544

Group type: EXPERIMENTAL
Intervention: High school attendance (≥80% school days)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: School dropout
Number of subjects: 0
Study: 26466908

Group type: EXPERIMENTAL
Intervention: Self-management support with pain science education and exercise (6-week program)
Number of subjects: 110

Group type: COMPARATOR
Intervention: Wait-list control
Number of subjects: 110
Study: 23416857

Group type: EXPERIMENTAL
Intervention: Methamphetamine (20 mg, oral) in paired conditions with contextual cues
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo in paired conditions with contextual cues
Number of subjects: 0

Group type: COMPARATOR
Intervention: Methamphetamine (20 mg, oral) in unpaired conditions
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo in unpaired conditions
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Paired group without monetary incentives
Number of subjects: 0
Study: 21203888

Group type: EXPERIMENTAL
Intervention: Treadmill exercise at 65% of peak VO2 for 1 hour during MF and ML phases
Number of subjects: 10

Group type: COMPARATOR
Intervention: Baseline evaluation
Number of subjects: 10
Study: 19671089

Group type: EXPERIMENTAL
Intervention: Tramadol Contramid OAD 100 mg
Number of subjects: 685

Group type: EXPERIMENTAL
Intervention: Tramadol Contramid OAD 200 mg
Number of subjects: 685

Group type: EXPERIMENTAL
Intervention: Tramadol Contramid OAD 300 mg
Number of subjects: 685

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 685
Study: 17460496

Group type: EXPERIMENTAL
Intervention: Cow's milk (CM)
Number of subjects: 65

Group type: COMPARATOR
Intervention: Infant formula (IF)
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Cow's milk (CM) with fish oil (FO) supplement
Number of subjects: 65

Group type: COMPARATOR
Intervention: Infant formula (IF) with fish oil (FO) supplement
Number of subjects: 65
Study: 14983576

Group type: EXPERIMENTAL
Intervention: Chromium supplementation (1000 micrograms)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 0
Study: 11783823

Group type: EXPERIMENTAL
Intervention: Electrical nerve stimulation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sham acupuncture
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Acupuncture, transcutaneous electrical nerve stimulation, acupuncture‐like transcutaneous nerve stimulation, laser therapy, neuroreflexotherapy
Number of subjects: 0
Study: 9493258

Group type: EXPERIMENTAL
Intervention: Vitamin A treatment (one capsule)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Vitamin A treatment (two doses)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Vitamin A treatment (no pills taken)
Number of subjects: 0
Study: 7831628

Group type: EXPERIMENTAL
Intervention: Exhalation TLCO (TLCO,ex)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Standard 10 second breath holding TLCO (TLCO,bh)
Number of subjects: 100
Study: 3071767

Group type: EXPERIMENTAL
Intervention: Calcium and phosphorus supplementation
Number of subjects: 26

Group type: COMPARATOR
Intervention: Control group (42 very low birth weight infants (VLBWI) and 83 LBWI appropriate for gestational age (AGA))
Number of subjects: 26
Study: 28952798

Group type: EXPERIMENTAL
Intervention: Lower BP target (SBP < 130 mm Hg)
Number of subjects: 1331
Study: 26303892

Group type: EXPERIMENTAL
Intervention: On-off design intervention
Number of subjects: 2

Group type: COMPARATOR
Intervention: Control group (off)
Number of subjects: 2
Study: 23161893

Group type: EXPERIMENTAL
Intervention: Community education program utilizing street dramas, poster campaigns, leaflets, and individual and group discussions.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control village with no intervention.
Number of subjects: 0
Study: 21534184

Group type: EXPERIMENTAL
Intervention: Mental practice for 'virtual movement' of the radiocarpal joint
Number of subjects: 21

Group type: COMPARATOR
Intervention: Not treated at all (Control)
Number of subjects: 21
Study: 18719064

Group type: EXPERIMENTAL
Intervention: Linezolid (LZD), 600 mg
Number of subjects: 149

Group type: COMPARATOR
Intervention: Vancomycin (VAN), 1 g every 12 h
Number of subjects: 149

Group type: EXPERIMENTAL
Intervention: Linezolid (LZD)
Number of subjects: 149

Group type: COMPARATOR
Intervention: Vancomycin (VAN)
Number of subjects: 149
Study: 16423119

Group type: EXPERIMENTAL
Intervention: Computer-assisted physician-directed intervention
Number of subjects: 235

Group type: COMPARATOR
Intervention: Control group (standard care)
Number of subjects: 235
Study: 12940564

Group type: EXPERIMENTAL
Intervention: UltraLume 2 LED light for 20 seconds
Number of subjects: 40

Group type: COMPARATOR
Intervention: Ortholux halogen curing light for 20 seconds
Number of subjects: 40